Launch Announced of 3D System for Ultrasound-Guided Spinal Anesthesia

The system is intended to prevent complications and improve outcomes during ultrasound-guided spinal anesthesia, and already has US FDA 510(k) clearance for spinal anesthesia guidance and other imaging applications, including diagnostic imaging of abdominal and musculoskeletal anatomies.

Will Mauldin, chairman and CEO of Rivanna Medical, said, “We have worked quickly to establish strategic, international distribution partnerships with local leaders such as Techno Orbits and Atlas Medical. These partnerships in Saudi Arabia and the United Arab Emirates, respectively, demonstrate the far-reaching significance and opportunity of our easy-to-use Accuro device. The Middle East expansion, combined with the level of regional market adoption we have seen for Accuro, is a strong indication of Rivanna Medical’s continued success on all fronts. If we can increase the efficiency of epidural and spinal anesthesia with fewer needle sticks, while reducing complications and costs then this is clearly an improvement for both the anesthesia community and the patient.”

Related Links:
Rivanna Medical